| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0013800 | Exon-Exon | chr10:31662051-31676727 | chr10:31373122-31387798 | 250 nt | 0.2800 |
| hsa_ZEB1_0015100 | Exon-Exon | chr10:31676053-31676195 | chr10:31387124-31387266 | 143 nt | 0.4476 |
| hsa_ZEB1_0015700 | Exon-Exon | chr10:31676053-31750166 | chr10:31387124-31461237 | 250 nt | 0.3920 |
| hsa_ZEB1_0017400 | Exon-Exon | chr10:31749966-31750166 | chr10:31461037-31461237 | 201 nt | 0.4279 |
| hsa_ZEB1_0017500 | Exon-Exon | chr10:31749966-31791437 | chr10:31461037-31502509 | 426 nt | 0.4484 |
| hsa_ZEB1_0017600 | Exon-Exon | chr10:31749966-31803636 | chr10:31461037-31514708 | 735 nt | 0.4204 |
| hsa_ZEB1_0019900 | Exon-Exon | chr10:31784705-31784767 | chr10:31495776-31495838 | 63 nt | 0.5397 |
| hsa_RP11-192P3.5_0000100 | Exon-Exon | chr10:31650393-31652934 | chr10:31361464-31364005 | 2542 nt | 0.6294 |
| hsa_RP11-192P3.5_0000200 | Exon-Exon | chr10:31652301-31652528 | chr10:31363372-31363599 | 228 nt | 0.5526 |
| hsa_RP11-192P3.5_0000300 | Intron-Intron | chr10:31657335-31658300 | chr10:31368406-31369371 | 966 nt | 0.3137 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].